Understanding Blood Clots: What Recent Research and Public Health Guidance Mean for You

Why blood clots matter

Blood clotting is a normal, lifesaving process. When you cut yourself, clotting stops the bleeding. But when a clot forms inside a vein or artery and blocks blood flow, it can become a medical emergency.

Each year in the United States, an estimated 900,000 people are affected by venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), according to the Centers for Disease Control and Prevention (CDC). DVT usually forms in a deep vein in the leg, while PE occurs when part of a clot breaks off and travels to the lungs.

Understanding who is at risk, what symptoms to watch for, and how prevention works can help families act quickly and reduce harm.

What are the main types of dangerous blood clots?

Deep vein thrombosis (DVT): A clot in a deep vein, most often in the leg. Symptoms can include swelling, pain, warmth, or redness in one leg.
Pulmonary embolism (PE): A clot that travels to the lungs. Symptoms may include sudden shortness of breath, chest pain (often worse with deep breathing), rapid heart rate, or coughing up blood.
Arterial clots: These can block blood flow to the heart (causing a heart attack) or brain (causing a stroke). Symptoms depend on the organ affected and usually come on suddenly.

Pulmonary embolism can be life-threatening and requires emergency care. Call 911 if someone has chest pain, trouble breathing, or collapses.

Who is at higher risk?

According to the CDC and the National Institutes of Health (NIH), several factors increase the risk of VTE:

Recent surgery or hospitalization
Major injury or trauma
Prolonged immobility (such as long flights or bed rest)
Pregnancy and the weeks after delivery
Cancer and certain cancer treatments
Use of estrogen-containing birth control or hormone therapy
Older age
Obesity
A personal or family history of blood clots
Inherited clotting disorders

Some people have more than one risk factor. For example, an older adult recovering from surgery who is less mobile may face a higher combined risk.

What recent research has focused on

Over the past few years, studies published in major medical journals such as NEJM and JAMA Network have continued to examine:

How long people should stay on blood thinners after a first clot
Which patients benefit most from extended anticoagulation (blood-thinning) therapy
Safer dosing strategies for people at higher bleeding risk
Clot risk after infections, including respiratory viruses

Many of these studies are randomized controlled trials—the gold standard for testing treatments. They compare different drug doses or treatment durations in large groups of patients. One consistent finding: blood thinners significantly reduce the risk of another clot, but they also increase the risk of bleeding. That tradeoff is why decisions are individualized.

Observational studies have also explored clot risk after hospitalization for infections and in people with chronic inflammatory conditions. These studies can show associations but cannot prove cause and effect. Still, they help guide prevention strategies in higher-risk settings.

How are blood clots treated?

The main treatment is anticoagulation, commonly called “blood thinners.” These medications do not dissolve clots instantly. Instead, they prevent clots from growing and reduce the risk of new clots while the body gradually breaks down the existing one.

Common options include direct oral anticoagulants (DOACs), heparin, and warfarin. The U.S. Food and Drug Administration (FDA) regulates these medications and provides safety information about dosing and bleeding risks.

Treatment length varies. Some people need blood thinners for three months. Others—especially those with ongoing risk factors—may need longer or even indefinite treatment.

What about prevention?

Prevention depends on your risk level.

During hospitalization: Many patients receive preventive doses of anticoagulants or wear compression devices on their legs.
After surgery: Doctors may prescribe short-term blood thinners, especially after orthopedic procedures like hip or knee replacement.
Travel or prolonged sitting: Standing up, walking, stretching your legs, and staying hydrated can help reduce risk.
Managing chronic conditions: Controlling cancer, heart disease, diabetes, and weight can lower overall clot risk.

If you have a strong family history of clots or an inherited clotting disorder, your clinician may recommend personalized prevention steps.

Bleeding risk: the other side of the equation

Because blood thinners reduce clotting, they increase bleeding risk. According to NIH and FDA safety guidance, signs of serious bleeding can include:

Unusual bruising
Prolonged nosebleeds
Blood in urine or stool
Severe headache or weakness (which could signal bleeding in the brain)

Anyone taking anticoagulants should discuss bleeding symptoms with their healthcare provider right away.

Oral health and blood thinners

For people on anticoagulants, dental care requires coordination—not avoidance. Routine cleanings and most minor dental procedures are usually safe, but dentists need to know about blood thinner use. Good oral hygiene also reduces gum inflammation, which can cause bleeding and complicate care.

If you are scheduled for dental surgery or extractions, your dentist and medical clinician may coordinate whether medication adjustments are needed. Do not stop a blood thinner without medical guidance.

When to seek medical care

Seek urgent medical attention if you have:

Sudden shortness of breath
Chest pain that worsens with breathing
Unexplained swelling or pain in one leg
Fainting or collapse

Early diagnosis improves outcomes. Imaging tests such as ultrasound (for DVT) or CT scans (for PE) help confirm the diagnosis.

What remains uncertain

Researchers continue to study which patients benefit most from extended blood thinner therapy, how to balance clot prevention with bleeding risk in older adults, and how emerging infections or chronic inflammatory diseases influence clot risk. As with many areas of medicine, recommendations evolve as more evidence becomes available.

What this means for readers

Blood clots are common, preventable in many cases, and treatable when caught early. Know the warning signs, understand your personal risk factors, and talk with your clinician before starting or stopping any blood-thinning medication. For families caring for older adults or people recovering from surgery, mobility and medication follow-up are especially important.

Reliable information from the CDC, NIH, FDA, and major medical journals can help you separate evidence-based guidance from online myths. Staying informed—and acting promptly when symptoms appear—can save lives.

This article is for general informational purposes only and is not medical advice. Research findings can be early, limited, or subject to change as new evidence emerges. For personal guidance, diagnosis, or treatment, consult a licensed clinician. For current outbreak or public health guidance, follow your local health department, the CDC, or another relevant public health authority.

Sources

Centers for Disease Control and Prevention (CDC) – Venous Thromboembolism (VTE)
National Institutes of Health (NIH) – Blood Clotting Disorders
U.S. Food and Drug Administration (FDA) – Anticoagulant Medication Safety
New England Journal of Medicine (NEJM) – Clinical trials on anticoagulation therapy
JAMA Network – Research on clot prevention and treatment